- Home
- CFR vs CAI Comparison
CFR vs CAI Comparison
Compare CFR & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFR | CAI |
|---|---|---|
| Founded | 1868 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.0B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | CFR | CAI |
|---|---|---|
| Price | $138.34 | $26.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $137.64 | $34.71 |
| AVG Volume (30 Days) | 434.3K | ★ 2.3M |
| Earning Date | 01-29-2026 | 02-12-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | ★ 20.47 | N/A |
| EPS | ★ 9.72 | N/A |
| Revenue | ★ $2,141,575,000.00 | $649,062,000.00 |
| Revenue This Year | $14.17 | $77.47 |
| Revenue Next Year | $4.38 | $35.87 |
| P/E Ratio | $14.26 | ★ N/A |
| Revenue Growth | 9.02 | ★ 112.02 |
| 52 Week Low | $100.31 | $22.86 |
| 52 Week High | $146.44 | $42.50 |
Technical Indicators
Market Signals| Indicator | CFR | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 68.85 | N/A |
| Support Level | $132.93 | N/A |
| Resistance Level | $138.15 | N/A |
| Average True Range (ATR) | 2.65 | 0.00 |
| MACD | 0.55 | 0.00 |
| Stochastic Oscillator | 88.43 | 0.00 |
Price Performance
Historical ComparisonAbout CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $53 billion in assets (as of September 2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.